06/05/2025
12:42 PM | Intra-Cellular Therapies (Subject)
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
| Form SCHEDULE 13G/A | |
04/14/2025
7:55 AM | Intra-Cellular Therapies (Filer)
| Form 15-12G | |
04/09/2025
11:15 PM | Intra-Cellular Therapies (Filer)
| Form EFFECT | |
04/02/2025
7:34 PM | Intra-Cellular Therapies (Issuer)
Salas Eduardo Rene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
4:46 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
4:47 PM | Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
4:41 PM | Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
4:43 PM | Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
4:30 PM | Intra-Cellular Therapies (Issuer)
Narula Sanjeev (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
4:30 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
4:30 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ITCI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Intra-Cellular Therapies and its competitors with MarketBeat's FREE daily newsletter. |
04/02/2025
4:32 PM | Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
3:32 PM | Intra-Cellular Therapies (Filer)
| Form POSASR | |
04/02/2025
3:12 PM | Intra-Cellular Therapies (Filer)
| Form POS AM | |
04/02/2025
3:13 PM | Intra-Cellular Therapies (Filer)
| Form S-8 POS | |
04/02/2025
8:02 AM | Intra-Cellular Therapies (Subject)
Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
03/31/2025
5:01 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
4:29 PM | Intra-Cellular Therapies (Filer)
| Form 10-K/A | |
03/18/2025
4:20 PM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2025
3:26 PM | Alexandria Venture Investments, LLC (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/10/2025
5:01 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
5:01 PM | Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
5:01 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
5:01 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
4:01 PM | Intra-Cellular Therapies (Subject)
JOHNSON & JOHNSON (Filed by)
| Form DFAN14A | |
03/04/2025
5:01 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:01 PM | Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:01 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:01 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
7:00 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2025
5:01 PM | Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
4:21 PM | Intra-Cellular Therapies (Subject)
JOHNSON & JOHNSON (Filed by)
| Form DFAN14A | |
02/21/2025
8:00 AM | Intra-Cellular Therapies (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/21/2025
7:21 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2025
9:23 AM | FMR LLC (Filed by)
Intra-Cellular Therapies (Subject)
| Form SCHEDULE 13G/A | |
02/04/2025
4:29 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:31 PM | Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:31 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:32 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:01 PM | Intra-Cellular Therapies (Issuer)
Narula Sanjeev (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
4:25 PM | Intra-Cellular Therapies (Subject)
JOHNSON & JOHNSON (Filed by)
| Form DFAN14A | |
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer? (Ad) Something extraordinary is happening in Washington.
For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations.
I'm talking about a $150 trillion American asset that's scattered across all 50 states.
While the mainstream media focuses on political theater, this story is quietly developing behind closed doors. We recently interviewed Rickards to get the full story and understand how everyday Americans can pre |
01/13/2025
4:27 PM | Intra-Cellular Therapies (Filer)
| Form DEFA14A | |
01/13/2025
4:27 PM | Intra-Cellular Therapies (Subject)
JOHNSON & JOHNSON (Filed by)
| Form DFAN14A | |
01/13/2025
6:47 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
6:48 AM | Intra-Cellular Therapies (Filer)
| Form DEFA14A | |
01/10/2025
5:46 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2025
5:01 PM | Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
5:01 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
3:27 PM | Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/03/2024
6:38 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
5:01 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
6:10 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2024
6:44 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2024
6:53 AM | Intra-Cellular Therapies (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/24/2024
1:02 PM | BlackRock, Inc. (Filed by)
Intra-Cellular Therapies (Subject)
| Form SC 13G/A | |
10/15/2024
5:00 PM | Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2024
11:36 AM | Intra-Cellular Therapies (Subject)
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
| Form SC 13G | |
10/02/2024
5:01 PM | Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2024
4:43 PM | Alexandria Venture Investments, LLC (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2024
5:01 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2024
3:06 PM | Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2024
3:34 PM | Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024
5:00 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2024
3:34 PM | Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
3:36 PM | Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2024
5:00 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:09 PM | Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
5:03 PM | Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
5:00 PM | Intra-Cellular Therapies (Issuer)
Narula Sanjeev (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/14/2024
5:01 PM | Intra-Cellular Therapies (Issuer)
Narula Sanjeev (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
6:55 AM | Intra-Cellular Therapies (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2024
6:49 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
